Curing hepatitis C with pills: a step toward global control.
Thomas
David L
DL
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. dthomas@jhmi.edu
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D003521:Cyclopropanes; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D054833:Isoindoles; D007769:Lactams / Q000008:administration & dosage*; D047029:Lactams, Macrocyclic; D011392:Proline / Q000031:analogs & derivatives; D013449:Sulfonamides / Q000008:administration & dosage*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
D000998:Antiviral Agents; D003521:Cyclopropanes; D003841:Deoxycytidine; D054833:Isoindoles; D007769:Lactams; D047029:Lactams, Macrocyclic; D011392:Proline; D013449:Sulfonamides; D017361:Viral Nonstructural Proteins; C552098:2'-fluoro-2'-methyl-3',5'-diisobutyryldeoxycytidine; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C553752:danoprevir